Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Lymphoid 2Other hematologic neoplasm 1Myeloid 1

Conditions

Prostatic Neoplasms 79Breast Neoplasms 7Neoplasms 6Prostate Adenocarcinoma 2Polycystic Ovary Syndrome 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Leiomyoma 2Hodgkin Disease 2Uveal Melanoma 1Urogenital Neoplasms 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Recurrence 1Prostatic Diseases 1Premenopausal Breast Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1PSA Level Greater Than Two 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms, Glandular and Epithelial 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Metabolic Syndrome 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphatic Metastasis 1Lower Urinary Tract Symptoms 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Rituximab 155Cyclophosphamide 120fludarabine phosphate 71Whole-Body Irradiation 55Mycophenolic Acid 54Etoposide 53Peripheral Blood Stem Cell Transplantation 46fludarabine 45Melphalan 44Granulocyte Colony-Stimulating Factor 43Busulfan 43Tacrolimus 39Filgrastim 37Vincristine 33Cyclosporine 31Bendamustine Hydrochloride 31Prednisone 29Doxorubicin 29Antilymphocyte Serum 28Methotrexate 27Cytarabine 27Lenalidomide 23Carmustine 22Bortezomib 22plerixafor 20Dexamethasone 19Thiotepa 17Stem Cell Transplantation 17Radiotherapy 17tositumomab I-131 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Lymphoma, Non-Hodgkin × Leuprolide × Clear all
NCT01343368 2017-12-05

Preservation of Ovarian Function After Hematopoietic Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
19 enrolled 19 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT00275262 2010-05-06

A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation

Abbott

Phase 2 Terminated
25 enrolled 12 charts
LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡